Global biopharmaceutical company providing safety, health and future

Company Overview

Pursuing Everyone’s Healthier Life

Vaccine DevelopmentVaccine Development

EuBiologics Co., Ltd. focuses on developing vaccines against global pandemic and creating bacterial vaccine pipelines against newly emerging infectious diseases and antibiotic resistance.
In addition to oral cholera vaccines, Eubiologics is in the process of developing
a variety of high-quality vaccines to improve the health of children around
the world and create new markets.

CRMO ServicesCRMO Services

EuBiologics provides personalized services to its customers
with respect to biomedicines (vaccine and protein therapeudics) research and development and commercialization.
Our services are designed to improve biological product quality and competitiveness, suited to all levels from research and development to the commercialization process.
Founded 10 March, 2010
CEO Yeong-Ok Baik, Seuk-Keun Choi
Address (Head Office) 8F, Seongdo Building, 207, Dosan-daero, Sinsa-dong, Gangnam-gu, Seoul, Korea
(Plant 1 / C Plant) BioVenture Plaza 4 and 5, 56, Soyanggang-ro, Chuncheon-si, Gangwon-do, Korea
(Plant 2 / V Plant) 125, Wonmudong-gil, Dongsan-myeon, Chuncheon-si, Gangwon-do, Korea
(R&D Center) 125, Wonmudong-gil, Dongsan-myeon, Chuncheon-si, Gangwon-do, Korea
Main Businesses * Vaccine Development and Supply
* CRMO Services
* Development of and Support for the Advanced Manufacturing Technologies for Biomedicines